logo

For the Inventor, By the Inventor

Springfield, NJ, United States of America

Tao Wang

This inventor holds 14 USPTO granted patents and 1 published patent application and 11 EPO patents. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Werthenstein Biopharma Gmbh. Active years: 2009-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Wang. Retrieved from https://idiyas.com/inventor/tao-wang-rigmvqd6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 71.4

 

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Sprinfield, NJ (US) (2009)
  • Springfield, NJ (US) (2009 - 2013)
  • Berkeley Heights, NJ (US) (2016 - 2018)
  • Cranford, NJ (US) (2023)

Company Filing History:

goldMedal10 out of 1,829 
 
Schering Corporation
 patents
silverMedal4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 2 
 
Werthenstein Biopharma Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11827614 - Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates (2023-11-28),
2. 9873707 - Methods and intermediates for preparing macrolactams (2018-01-23),
3. 9238604 - Process and intermediates for preparing macrolactams (2016-01-19),
4. 8618314 - Exo- and diastereo-selective synthesis of himbacine analogs (2013-12-31),
5. 8273790 - Exo-selective synthesis of himbacine analogs (2012-09-25),
6. 8258319 - Exo- and diastereo- selective synthesis of himbacine analogs (2012-09-04),
7. 8138180 - Exo-selective synthesis of himbacine analogs (2012-03-20),
8. 7989653 - Exo- and diastereo-selective syntheses of himbacine analogs (2011-08-02),
9. 7772276 - Exo-selective synthesis of himbacine analogs (2010-08-10),
10. 7678948 - Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof (2010-03-16),
11. 7626045 - Synthesis of himbacine analogs (2009-12-01),
12. 7605275 - Exo- and diastereo- selective syntheses of himbacine analogs (2009-10-20),
13. 7553987 - Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof (2009-06-30),
14. 7541471 - Synthesis of himbacine analogs (2009-06-02),

Title: The Inventor Profile: Tao Wang

Introduction:

Tao Wang, a renowned inventor based in Springfield, NJ (US), has made significant contributions to the field of pharmaceuticals with a notable portfolio of 14 patents. His innovative work focuses on enhancing treatments for cancer and viral infections.

Latest Patents:

1. Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates: Wang's patent discloses crystalline forms of synthetic intermediates crucial for producing belzutifan, a potent HIF-2𝝰 inhibitor for cancer therapy.

2. Methods and intermediates for preparing macrolactams: This patent includes compounds that serve as key intermediates in the synthesis of macrolactams, with applications in inhibiting HCV NS3 protease for therapeutic and research purposes.

Career Highlights:

Tao Wang's expertise has been honed through employment at prestigious companies like Schering Corporation and Merck Sharp & Dohme Corporation. His innovative spirit and dedication to advancing pharmaceutical science have propelled him to the forefront of the industry.

Collaborations:

Throughout his career, Wang has collaborated with esteemed professionals such as Tiruvettipuram K Thiruvengadam and Jing Liao, enriching his projects with diverse perspectives and expertise. These collaborations have led to groundbreaking advancements in drug development and treatment modalities.

Conclusion:

In conclusion, Tao Wang's inventive prowess and commitment to improving healthcare through innovative pharmaceutical solutions have solidified his reputation as a leading inventor in the field. His patents and collaborations reflect a legacy of excellence that continues to inspire future generations in the realm of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…